Kamau Therapeutics, operates from its headquarter in South San Francisco, California 94080, US. The company operates in the Business Services, Research & Development sector.
Kamau Therapeutics specializes in High efficiency targeted gene integration, Homology-directed repair (HDR), Gene editing, Clinical-stage biotechnology research, and offers services including Next-generation gene correction therapies, One-time curative cell therapies, and Novel gene correction approach (HDR).